Shockwave Medical, Inc.
SWAVDelisted May 31, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001642545
Shockwave Medical, Inc. was delisted on May 31, 2024; its insiders filed their last Form 4 on May 31, 2024; 487 institutions reported holding it in 13F filings for Q1 2024, worth $12.0B in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:48 PM ET
Revenue flow, FY2023
Where the revenue went in FY2023, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 15, 2024 | Jan 17, 2023 | Feb 17, 2022 | Feb 17, 2021 | Feb 13, 2020 |
| Revenue | $730.2M | $489.7M | $237.1M | $67.8M | $42.9M |
| Cost of revenue | $95.4M | $65.0M | $41.4M | $21.0M | $17.2M |
| Gross profit | $634.8M | $424.7M | $195.7M | $46.8M | – |
| Research and development | $145.6M | $81.7M | $50.5M | $36.9M | $32.9M |
| Selling, general and administrative | $95.3M | $56.9M | $34.7M | $23.9M | $14.1M |
| Operating income | $159.1M | $124.1M | -$871.0K | -$65.7M | -$51.8M |
| Interest expense | $6.91M | $1.89M | $1.10M | $1.21M | $944.0K |
| Income tax | $27.0M | -$95.2M | $301.0K | $80.0K | $62.0K |
| Net income | $147.3M | $216.0M | -$9.14M | -$65.7M | -$51.1M |
| EPS, basic | $4.01 | $6.02 | – | – | – |
| EPS, diluted | $3.85 | $5.70 | – | – | – |
| Weighted shares, basic | 36.7M | 35.9M | – | – | – |
| Weighted shares, diluted | 38.2M | 37.9M | – | – | – |
| Margins and growth | |||||
| Gross margin | 86.9% | 86.7% | 82.5% | 69.0% | – |
| Operating margin | 21.8% | 25.3% | -0.4% | -96.9% | -120.8% |
| Net margin | 20.2% | 44.1% | -3.9% | -96.9% | -119.1% |
| Revenue growth, year over year | +49.1% | +106.5% | +249.8% | +57.9% | – |
| Net income growth, year over year | −31.8% | – | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 15, 2024 | Jan 17, 2023 | Feb 17, 2022 | Feb 17, 2021 | Feb 13, 2020 |
| Cash and equivalents | $328.4M | $156.6M | $89.2M | $50.4M | $139.0M |
| Short-term investments | $662.1M | $147.9M | $111.8M | $151.9M | $56.3M |
| Accounts receivable | $114.6M | $71.4M | $37.4M | $11.7M | $7.38M |
| Inventory | $107.6M | $75.1M | $43.0M | $29.9M | $12.1M |
| Total current assets | $1.23B | $459.3M | $285.9M | $246.3M | $216.7M |
| Property, plant and equipment | $68.9M | $48.2M | $24.4M | $16.4M | $4.91M |
| Goodwill | $39.6M | – | – | – | – |
| Intangible assets | $92.9M | – | – | – | – |
| Total assets | $1.57B | $646.1M | $345.7M | $272.0M | $231.9M |
| Accounts payable | $8.87M | $6.72M | $3.52M | $1.47M | $2.79M |
| Short-term debt | – | $0 | $5.50M | $3.30M | $6.67M |
| Total current liabilities | $104.2M | $63.4M | $51.6M | $25.6M | $24.0M |
| Long-term debt | – | $24.2M | $11.6M | $13.3M | $7.15M |
| Total liabilities | $897.9M | $134.8M | $103.9M | $46.4M | $39.3M |
| Shareholders' equity | $668.7M | $511.3M | $241.8M | $225.7M | $192.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 15, 2024 | Jan 17, 2023 | Feb 17, 2022 | Feb 17, 2021 | Feb 13, 2020 |
| Operating cash flow | $196.1M | $117.7M | $15.0M | -$71.2M | -$48.1M |
| Capital expenditures | $30.6M | $25.1M | $12.4M | $11.5M | $3.82M |
| Free cash flow | $165.5M | $92.6M | $2.60M | -$82.7M | -$51.9M |
| Depreciation and amortization | $10.4M | $4.86M | $3.58M | $1.86M | $1.34M |
| Stock-based compensation | $73.2M | $44.9M | $27.3M | $10.3M | $3.65M |
| Investing cash flow | -$625.7M | -$62.1M | $26.4M | -$107.5M | -$59.5M |
| Financing cash flow | $600.4M | $13.0M | -$2.45M | $90.0M | $208.1M |
| Net change in cash | $171.5M | $67.4M | $39.0M | -$88.6M | $100.4M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 10.0% | 9.2% | 11.5% | 15.3% | 8.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| May 1, 2024 | 37.5M | +2.5% | SEC |
| Apr 22, 2024 | 37.5M | +2.4% | SEC |
| Feb 21, 2024 | 37.4M | +2.5% | SEC |
| Nov 1, 2023 | 36.9M | +2.1% | SEC |
| Aug 2, 2023 | 36.8M | +2.3% | SEC |
| May 2, 2023 | 36.6M | +2.3% | SEC |
| Feb 22, 2023 | 36.5M | +2.4% | SEC |
| Nov 1, 2022 | 36.1M | +2.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.